Glaxosmithkline Plc Turning Point Therapeutics, Inc. (TPTX) insider trading activity

GLAXOSMITHKLINE PLC Transaction History

Date	Transaction	Value	Shares Traded
May 21 2020	BUY Open market or private purchase	$4,999,980 $60.0 p/Share	83,333
Sep 10 2019	BUY Open market or private purchase	$7,999,965 $45.0 p/Share	177,777
Apr 22 2019	BUY Open market or private purchase	$5,850,000 $18.0 p/Share	325,000
Apr 22 2019	BUY Conversion of derivative security	-	1,667,550

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

> 10% Shareholder

SPRO

Spero Therapeutics, Inc. Healthcare

> 10% Shareholder

TBIO

Translate Bio, Inc. Healthcare

> 10% Shareholder

LQDA

Liquidia Technologies Inc

PRNB

Principia Biopharma Inc.

CCXI

ChemoCentryx, Inc.

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

GNCA

GENOCEA BIOSCIENCES, INC. Healthcare

> 10% Shareholder

MORF

Morphic Holding, Inc. Healthcare

Director

FULC

Fulcrum Therapeutics, Inc. Healthcare

PGNY

Progyny, Inc. Healthcare

> 10% Shareholder

NKTX

Nkarta, Inc. Healthcare

Director

PAND

Pandion Therapeutics, Inc.

Director

DBTX

Decibel Therapeutics, Inc. Healthcare

Director

INVA

Innoviva, Inc. Healthcare

> 10% Shareholder

LYEL

Lyell Immunopharma, Inc. Healthcare

> 10% Shareholder

CVRX

CVRx, Inc. Healthcare

> 10% Shareholder

TBPH

Theravance Biopharma, Inc. Healthcare

WVE

Wave Life Sciences Ltd. Healthcare

> 10% Shareholder